News & Views

• Occam Places Ryan Kruger as CSO of Anagenex
  November 22, 2022
• Occam Places Leo Wossnig as CTO of LabGenius
  November 16, 2022
• Occam Places John McDonald on Board of Geron
  September 16, 2022
• Occam Places Bimal Shah as CFO of Corium
  September 10, 2022
• Occam Places Bell Zhong as CFO at Neomorph
  September 8, 2022
• Occam Places Padma Sundar as CBO at ChromaCode
  September 4, 2022
• Occam Places Jorge Bartolome as CEO at Areteia Therapeutics
  August 10, 2022
• Occam Recruits Michael Miller to the Board of BioXcel
  August 4, 2022
• Occam Places Dan Marquess as CSO at Vicinitas Therapeutics
  July 28, 2022
• Occam Places Paul Thibodeau as CBO of Hotspot
  July 25, 2022
• Occam Places Amber Salzman as CEO of Epic Bio
  July 12, 2022
• Occam Places Colin McCracken as Chief Executive Officer at Evonetix
  June 13, 2022
• Occam Places Gary Glick as Chairman at CHARM Therapeutics
  June 9, 2022
• Occam Places Juan Estupinan as Chief Financial Officer at Vestaron
  June 7, 2022
• Occam Places Ryan Kelly as Chief Communications Officer at Recursion
  May 17, 2022
• Occam Places Kali Stasi as SVP Clinical Development at Tenpoint Therapeutics
  May 13, 2022
• Occam Places Rabia Gurses Ozden as Board Member at Adverum
  April 22, 2022
• Occam Places Craig Thompson as CEO at Cerevance
  April 21, 2022
• Occam Places Steve Staben as CSO at Lycia Therapeutics
  March 11, 2022
• Occam Places Scott Saywell as Chief Business Officer at Herophilus
  March 10, 2022
• Occam Places Elaine Sun on the Board of Dynavax
  February 23, 2022
• Occam Places Richard Beckman as CMO at Adverum
  February 11, 2022
• Occam Places Emily Conley on the Board of Nuvalent
  February 5, 2022
• Strategic Recruiting for insitro
  January 12, 2022
• Occam Places David Mullarkey as CEO at Bluestar
  January 10, 2022
• Occam Places Lisa Deschamps as CEO of AviadoBio
  December 3, 2021
• Occam Places Ed Koval as CBO at Geron
  December 2, 2021
• Occam Places Andreas Grauer as CMO at Federation Bio
  December 1, 2021
• Occam Places Gino Van Heeke as CSO at LabGenius
  November 30, 2021
• Occam Places Scott Myers on the Board of Dynavax
  October 28, 2021
• Occam Places David Lynch as CBO of Strateos
  October 13, 2021
• Occam Places Emile Nuwaysir as CEO of Ensoma
  October 11, 2021
• Occam Places Hans Bitter as SVP and Head, Data Science of MOMA Therapeutics
  October 8, 2021
• Occam Places Alan Ashworth on the Board of CytomX
  October 4, 2021
• Occam Places Wendy Young as Executive Partner at MPM Capital
  September 1, 2021
• Occam Places Jim Wang as SVP, Regulatory Affairs at Adverum
  August 23, 2021
• Occam Places Sapna Srivastava on the Board of Nuvalent
  July 15, 2021
• Occam Places Mike Sherman on Board of Werewolf Therapeutics
  June 20, 2021
• Occam Places Chulani Karunatilake as CTO at Werewolf Therapeutics
  June 15, 2021
• Occam Places Jeff Landau as CBO and Chau Cheng as VP IR at CytomX Therapeutics
  June 8, 2021
• Occam Places Paul Audhya as CMO at KalVista Pharmaceuticals
  May 3, 2021
• Occam Places Vatnak Vat-Ho as CBO at Ryvu Therapeutics
  April 28, 2021
• Occam Places Teresa McRoberts as CFO at Triumvira Immunologics
  April 27, 2021
• Occam Places Ann Taylor, CMO of AstraZeneca, on Board of Unlearn.AI
  March 10, 2021
• Occam Places Wildon Farwell as CMO at Dyne Therapeutics
  March 4, 2021
• Occam Places Louisa Daniels as General Counsel at Recursion
  February 18, 2021
• Occam Places Tim Trost as CFO at Werewolf Therapeutics
  February 13, 2021
• Occam Places Brian Goldman as SVP and Chief Computation Officer at ZebiAI
  February 9, 2021
• Occam Places Annette Matthies as CBO at Elicio
  February 2, 2021
• Occam Places Ramona Doyle as CMO at Recursion
  January 13, 2021
• Occam Places Andrew Hall as CBO at IMV
  November 13, 2020
• The Importance of CEO Leadership
  November 3, 2020
• Occam Client and Alvin Shih Led Disarm Therapeutics to be Acquired By Eli Lilly
  October 15, 2020
• Occam Client and Ted Ashburn Led Oncorus Launches IPO
  October 7, 2020
• Emly Conley secures $50M in financing to advance Federation Bio’s microbial platform
  October 6, 2020
• Occam Places Ali Fattaey as CEO of Metabomed
  September 11, 2020
• Occam Places Vijay Reddy as Chief Research & Development Officer of Tmunity Therapeutics
  September 9, 2020
• Occam Places Christopher Silber as Chief Medical Officer of Nocion Therapeutics
  September 1, 2020
• Occam Places Ellen Lubman as Chief Business Officer of Werewolf Therapeutics
  August 13, 2020
• Occam Places Michael Bailey on the Board of IMV Inc.
  July 22, 2020
• Occam Places Emily Conley as CEO of Federation Bio
  July 20, 2020
• BlackRock Leads $50 Million Round in Hydropanel Startup Zero Mass Water
  June 17, 2020
• Occam Remains Alive and Well in the Time of COVID
  June 10, 2020
• Occam Places Matthew Gall as CFO of iTeos Therapeutics
  
• Occam client Accent Therapeutics forms cancer therapeutics collaboration with AstraZeneca
  June 4, 2020
• Variant Bio Aims to Make Use of Humanity’s Genetic Outliers
  May 28, 2020
• Generation Bio tees up $125M IPO to push next-gen gene therapies
  May 26, 2020
• Occam Places Terry-Ann Burrell on the Board of Recursion Pharmaceuticals
  May 5, 2020
• Occam Places Don Manning as CMO of Pacira Biosciences
  May 1, 2020
• Occam Places Gates Foundation Leader as CEO at Variant Bio
  April 6, 2020
• Occam Places Carlos Campoy as SVP & CFO at CytomX
  March 27, 2020
• Occam Places CEO at Ivenix, an F-Prime/WuXi Backed Medical Device Company
  January 20, 2020
• Occam Places Terry-Ann Burrell as CFO at Beam Therapeutics
  September 4, 2019
• Occam Places Robert Bartrop as Chief Revenue Officer at Zero Mass Water
  April 1, 2017